Drugs / LWP779
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07371455 | Mar → Jul 2026 overdue | ischemic stroke | Longwood Pharmaceuticals (Hangzhou) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LWP779 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07371455 ↗ |
| Route | Oral | “after oral administration in healthy participants” NCT07371455 ↗ |